Lascuña, Judi Ann .
HRN: 26-72-75 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2025
CEFUROXIME 500MG (TAB)
09/27/2025
10/04/2025
PO
500 Mg
BID
S/P NSVD With RMLE
Checking Initial Appropriateness
09/29/2025
CEFUROXIME 500MG (TAB)
09/29/2025
10/04/2025
PO
500mg
BID
NSVD With RMLE
Checking Final Appropriateness